- ►annals.org [PDF] V Sundararajan, N Mitra, JS Jacobson, VR … - Annals of internal medicine, 2002 - Am Coll Physicians Background: Randomized clinical trials have demonstrated the efficacy of
adjuvant 5-fluorouracil (5-FU)–based chemotherapy af- ter surgical resection
of node-positive colon cancer. Although this treatment became the standard ... Cited by 107 - Related articles - BL Direct - All 6 versions
- ►ascopubs.org TJ Iwashyna, EB Lamont - Journal of Clinical Oncology, 2002 - jco.ascopubs.org PURPOSE: Although randomized controlled trials (RCTs) consistently show that
adjuvant fluorouracil (5-FU) extends the survival of patients with stage III
colon cancer, it is not yet known whether this benefit exists in ... Cited by 84 - Related articles - BL Direct - All 7 versions
V Sundararajan, VR Grann, JS Jacobson, H … - Cancer journal (Sudbury, Mass.) - ncbi.nlm.nih.gov BACKGROUND: Since 1990, the recommended adjuvant therapy for patients with
surgically resected node-positive colon cancer has been 5-fluorouracil (5-FU),
usually in combination with leucovorin or levamisole. The purpose of this ... Cited by 58 - Related articles - BL Direct
- ►oxfordjournals.org D Schrag, LD Cramer, PB Bach, CB Begg - JNCI Journal of the National Cancer Institute, 2001 - jnci.oxfordjournals.org Background: Randomized trials have established that 5-fluorouracil-based
adjuvant chemotherapy following resection of stage III colon cancer reduces
subsequent mortality by as much as 30%. However, the extent to which ... Cited by 206 - Related articles - BL Direct - All 9 versions
- ►ascopubs.org AI Neugut, AT Fleischauer, V Sundararajan, N … - Journal of Clinical Oncology, 2002 - jco.ascopubs.org PATIENTS AND METHODS: The linked Surveillance, Epidemiology, and
End-Results–Medicare database was used to identify 1,807 Medicare
beneficiaries 65 years of age with stage II or III rectal cancer who ... Cited by 84 - Related articles - BL Direct - All 7 versions
DJ Sargent, RM Goldberg, SD Jacobson, JS … - New England Journal of Medicine, 2001 - content.nejm.org Methods We performed a pooled analysis, based on the intention to treat, of
individual patient data from seven phase 3 randomized trials (involving 3351
patients) in which the effects of postoperative fluorouracil plus ... Cited by 374 - Related articles - BL Direct - All 8 versions
JM Jessup, A Stewart, FL Greene, BD Minsky - Jama, 2005 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context A 1990 National ... Cited by 77 - Related articles - BL Direct - All 5 versions
- ►ascopubs.org AI Neugut, M Matasar, X Wang, R McBride, … - Journal of Clinical Oncology, 2006 - jco.ascopubs.org Purpose In randomized trials, patients with stage III colon cancer who received
6 months of fluorouracil (FU)-based adjuvant chemotherapy had better survival
than patients who did not. However, little is known about the predictors ... Cited by 35 - Related articles - All 7 versions
- ►ascopubs.org RA Popescu, A Norman, PJ Ross, B Parikh, … - Journal of Clinical Oncology, 1999 - jco.ascopubs.org Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
From the Gastrointestinal Unit, Royal Marsden Hospital, London, and Sutton, ... Cited by 163 - Related articles - BL Direct - All 7 versions
SA Dobie, LM Baldwin, JA Dominitz, B … - JNCI Journal of the National Cancer Institute, 2006 - jnci.oxfordjournals.org Background: Certain factors, such as race or age, are known to be associated
with variation in initiation of adjuvant chemotherapy for stage III colon
cancer, but little is known about what factors are associated with ... Cited by 36 - Related articles - BL Direct - All 8 versions
